{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Sparfosate_Sodium",
  "nciThesaurus": {
    "casRegistry": "66569-27-5",
    "chebiId": "",
    "chemicalFormula": "C6H8NO8P.2Na",
    "definition": "The disodium salt form of N-phosphonacetyl-L-aspartate (PALA), a pyrimidine antimetabolite with antineoplastic activity.  PALA inhibits pyrimidine biosynthesis and increases the extent to which fluorouracil is incorporated into RNA.",
    "fdaUniiCode": "5R33Q73DYD",
    "identifier": "C2353",
    "preferredName": "Sparfosate Sodium",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [
      "C272",
      "C471"
    ],
    "synonyms": [
      "CI-882",
      "L-Aspartic Acid, N-(phosphonoacetyl)-, Disodium Salt",
      "N-Phosphonacetyl-L-aspartate Disodium",
      "PALA Disodium",
      "SPARFOSATE SODIUM",
      "Sparfosate Sodium"
    ]
  }
}